I realize this may be crazy now but just wondering if any long term holders have bought more? I bought this stock at a point where I am still profiting. I always understood this was a risky stock but I believe in it. GSK is out. There is still a chance for FDA approval just maybe not an accelerated one.
Sold everything in PM tuesday to preserve capital. Back in today to re-establish a core position. The only thing worse than taking a big loss is getting shaken out and being sidelined when it comes roaring back. This event smells a lot like what happened with ARNA when the FDA pulled rats and mice out of their hind end.
Yes, but am disgusted with my numbers. Sold at 54.00, 10/7/13, excellent profit. Afraid of missing out on 'the big run-up,' I jumped right back in at 55.00!! If only I had shorted instead. Bought more yesterday at 14.14. Am very familiar with biotech stocks, but admit, I was shocked by the latest SRPT drop.
At this point one needs to ask one's self...does this technology have value? ...because the company is sitting on approx. $7 per share cash. What could the technology be worth? I got crushed Tuesday but have made a drecision to add more here. The risk/reward is very favorable. Also there was something very wierd about the FDA statement Tues. It doesn't add up. It's one thing for them to call into question the trial size, but to comment on the 6mwt as being highly questionable etc. Their about face on this was very irrational. Maybe they are just "doing their job" but considering this is the only potentially viable treatment for DMD on the horizon, something is going to happen here- to the upside for Sarepta. Anyone agree?